These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 19810292

  • 1. Frequency of hepatorenal syndrome among cirrhotics.
    Kumar R, Ahmed R, Rathi SK, Sethar GH.
    J Coll Physicians Surg Pak; 2005 Oct; 15(10):590-3. PubMed ID: 19810292
    [Abstract] [Full Text] [Related]

  • 2. Serum cystatin C level is a good prognostic marker in patients with cirrhotic ascites and normal serum creatinine levels.
    Seo YS, Jung ES, An H, Kim JH, Jung YK, Kim JH, Yim HJ, Yeon JE, Byun KS, Kim CD, Ryu HS, Um SH.
    Liver Int; 2009 Nov; 29(10):1521-7. PubMed ID: 19725889
    [Abstract] [Full Text] [Related]

  • 3. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.
    Martín-Llahí M, Pépin MN, Guevara M, Díaz F, Torre A, Monescillo A, Soriano G, Terra C, Fábrega E, Arroyo V, Rodés J, Ginès P, TAHRS Investigators.
    Gastroenterology; 2008 May; 134(5):1352-9. PubMed ID: 18471512
    [Abstract] [Full Text] [Related]

  • 4. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.
    Wong F, Pantea L, Sniderman K.
    Hepatology; 2004 Jul; 40(1):55-64. PubMed ID: 15239086
    [Abstract] [Full Text] [Related]

  • 5. Review article: Management of ascites and associated complications in patients with cirrhosis.
    Kuiper JJ, de Man RA, van Buuren HR.
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():183-93. PubMed ID: 18081661
    [Abstract] [Full Text] [Related]

  • 6. Hepatorenal Syndrome In Patients With Cirrhosis Of Liver According To 2007 International Ascites Club Criteria.
    Seetlani NK, Memon AR, Iftikhar F, Ali A, Fazel PA.
    J Ayub Med Coll Abbottabad; 2016 Dec; 28(3):578-581. PubMed ID: 28712240
    [Abstract] [Full Text] [Related]

  • 7. Hyponatremia in cirrhosis: Results of a patient population survey.
    Angeli P, Wong F, Watson H, Ginès P, CAPPS Investigators.
    Hepatology; 2006 Dec; 44(6):1535-42. PubMed ID: 17133458
    [Abstract] [Full Text] [Related]

  • 8. Aquaporin-1 and aquaporin-2 urinary excretion in cirrhosis: Relationship with ascites and hepatorenal syndrome.
    Esteva-Font C, Baccaro ME, Fernández-Llama P, Sans L, Guevara M, Ars E, Jiménez W, Arroyo V, Ballarín JA, Ginès P.
    Hepatology; 2006 Dec; 44(6):1555-63. PubMed ID: 17133493
    [Abstract] [Full Text] [Related]

  • 9. Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome.
    Moore K, Wendon J, Frazer M, Karani J, Williams R, Badr K.
    N Engl J Med; 1992 Dec 17; 327(25):1774-8. PubMed ID: 1435931
    [Abstract] [Full Text] [Related]

  • 10. Hepatorenal syndrome: diagnostic accuracy, clinical features, and outcome in a tertiary care center.
    Watt K, Uhanova J, Minuk GY.
    Am J Gastroenterol; 2002 Aug 17; 97(8):2046-50. PubMed ID: 12190175
    [Abstract] [Full Text] [Related]

  • 11. Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis.
    Hampel H, Bynum GD, Zamora E, El-Serag HB.
    Am J Gastroenterol; 2001 Jul 17; 96(7):2206-10. PubMed ID: 11467654
    [Abstract] [Full Text] [Related]

  • 12. Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation.
    Campbell MS, Kotlyar DS, Brensinger CM, Lewis JD, Shetty K, Bloom RD, Markmann JF, Olthoff KM, Shaked A, Reddy KR.
    Liver Transpl; 2005 Sep 17; 11(9):1048-55. PubMed ID: 16123966
    [Abstract] [Full Text] [Related]

  • 13. Renal duplex Doppler ultrasound in patients with HCV related liver cirrhosis.
    Fouad YM, Mokarrab H, Elgebaly AF, El-Amin H, Abdel-Raheem EM, Sharawy MA, Shatat ME.
    Trop Gastroenterol; 2009 Sep 17; 30(4):213-8. PubMed ID: 20426281
    [Abstract] [Full Text] [Related]

  • 14. [Hepatorenal syndrome].
    Mijac D, Kezić A, Stojimirović B.
    Srp Arh Celok Lek; 2007 Sep 17; 135(1-2):98-104. PubMed ID: 17503577
    [Abstract] [Full Text] [Related]

  • 15. [Analysis of the relationship between hepatorenal syndrome and plasma ammonia].
    He Y, Li GX, Xia Y.
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jan 17; 18(1):45-8. PubMed ID: 20128969
    [Abstract] [Full Text] [Related]

  • 16. Terlipressin in 30 patients with hepatorenal syndrome: results of a retrospective study.
    von Kalckreuth V, Glowa F, Geibler M, Lohse AW, Denzer UW.
    Z Gastroenterol; 2009 Jan 17; 47(1):21-6. PubMed ID: 19156588
    [Abstract] [Full Text] [Related]

  • 17. [Hepatorenal syndrome in patients with liver cirrhosis].
    Zaza S, Bonny O, Liaudet L.
    Nephrol Ther; 2005 Jul 17; 1(3):174-82. PubMed ID: 16895684
    [Abstract] [Full Text] [Related]

  • 18. Fluid retention in cirrhosis: pathophysiology and management.
    Kashani A, Landaverde C, Medici V, Rossaro L.
    QJM; 2008 Feb 17; 101(2):71-85. PubMed ID: 18184668
    [Abstract] [Full Text] [Related]

  • 19. Outcomes for hepatorenal syndrome and acute kidney injury in patients undergoing liver transplantation: a single-center experience.
    Shusterman B, Mchedishvili G, Rosner MH.
    Transplant Proc; 2007 Jun 17; 39(5):1496-500. PubMed ID: 17580171
    [Abstract] [Full Text] [Related]

  • 20. Midodrine in the prevention of hepatorenal syndrome type 2 recurrence: a case-control study.
    Alessandria C, Debernardi-Venon W, Carello M, Ceretto S, Rizzetto M, Marzano A.
    Dig Liver Dis; 2009 Apr 17; 41(4):298-302. PubMed ID: 19158001
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.